How Multilayer Oromucosal Films Are Designed for Directional Delivery

Multilayer oromucosal films are designed for directional delivery by assigning different functions to separate material layers. A mucoadhesive peptide-containing layer is positioned against oral mucosa, while a backing layer is engineered to reduce peptide loss toward saliva and the oral cavity. Researchers evaluate interlayer adhesion, backing-layer permeability, peptide release from each side, film thickness, flexibility, mucoadhesion, hydration, and transmucosal permeation. Directional delivery therefore depends on the complete film architecture rather than simply adding a second polymer layer.

Multilayer design expands Oromucosal Peptide Film Research from formulation chemistry into spatial engineering. Instead of asking only what ingredients belong in a film, researchers ask where each ingredient should be positioned and in which direction peptide and excipients should move after hydration.

Research-use notice: This article examines multilayer and bilayer oromucosal peptide-film engineering, including mucoadhesive drug layers, backing layers, interlayer compatibility, directional release, and mucosa-facing peptide transport. InStrips products are offered for research and analytical evaluation only and are not intended to diagnose, treat, cure, or prevent peptide absorption disorders, oral disease, mucosal conditions, systemic disease, or any other medical condition.

The purpose of directional design is not to alter the peptide molecule. It is to control the physical path available to the peptide after the film hydrates.

A Single-Layer Film Can Release in More Than One Direction

When a hydrated monolayer film is attached to buccal tissue, peptide can potentially move:

• toward the mucosa
• toward saliva
• laterally through the hydrated matrix

Only the mucosa-facing fraction contributes directly to transmucosal delivery.

Release Toward Saliva Can Represent Formulation Loss

Peptide released into the oral cavity can be:

• diluted by saliva
• swallowed
• removed from the intended absorption site

This reduces directional efficiency.

A Backing Layer Attempts to Restrict the Unwanted Path

A bilayer design places a less permeable layer on the side facing the oral cavity.

The intended transport path becomes:

backing layer → peptide-containing layer → mucosa

rather than approximately symmetrical release from both film surfaces.

The Backing Layer and Mucoadhesive Layer Have Different Jobs

The mucosa-facing layer may need to provide:

• peptide loading
• hydration
• mucoadhesion
• peptide release
• permeation-enhancer delivery

The backing layer may need to provide:

• reduced water permeability
• reduced peptide passage
• structural support
• handling strength

Using Separate Layers Allows Formulation Roles to Be Decoupled

A polymer that provides excellent mucoadhesion may be too water soluble to function as a backing material.

A more hydrophobic polymer may provide a good barrier but poor mucosal adhesion.

Bilayer design lets researchers use both materials for different purposes.

The Peptide Layer Must Face the Correct Direction

Orientation matters during both:

• laboratory permeation studies
• eventual application research

A bilayer film placed backward would not reproduce its intended release geometry.

Visual Differentiation Can Help Layer Orientation

Researchers may distinguish layers through:

• appearance
• surface texture
• thickness
• material contrast

although formulation changes must not compromise peptide stability or testing.

The Backing Polymer Must Remain Compatible With the Drug Layer

Two individually suitable polymers can behave poorly when laminated together.

Potential problems include:

• delamination
• warping
• differential swelling
• poor interfacial adhesion

Interlayer Adhesion Is a Critical Quality Attribute

If the layers separate during:

• cutting
• packaging
• handling
• hydration

the directional-delivery concept fails structurally.

Layer Interfaces Can Be Studied Experimentally

Material interactions at the interface may be examined using methods such as:

• microscopy
• spectroscopy
• mechanical testing
• surface-interaction techniques

This helps determine whether layers form a stable composite.

Manufacturing Sequence Matters

A bilayer film may be produced by:

• casting one layer first
• partially or fully drying it
• casting the second layer
• drying the combined structure

The sequence can influence interlayer bonding.

Over-Drying the First Layer Can Reduce Interfacial Interaction

If the first layer becomes highly dry and rigid, the second wet layer may not integrate sufficiently with it.

Partial hydration at the interface can sometimes promote better adhesion, depending on the polymers used.

Too Much Solvent Exposure Can Create a Different Problem

The second casting solution may:

• partially dissolve the first layer
• cause polymer mixing
• disturb directional architecture

Manufacturing conditions therefore require optimization.

Backing Layers Can Use Less Water-Soluble Polymers

Materials with lower aqueous permeability can reduce peptide transport toward the oral cavity.

One recent peptide-film approach used an ammonio-methacrylate copolymer as the backing layer.

Eudragit RLPO Has Been Used in Peptide Bilayer Research

Eudragit RLPO provides a polymer structure different from water-soluble pullulan and carboxymethyl cellulose.

Its placement behind the mucoadhesive peptide layer can create a less permissive path for outward peptide release.

The Backing Layer Does Not Need to Be Completely Impermeable

Absolute impermeability may not be necessary.

Researchers can instead ask whether it:

• reduces reverse release sufficiently
• maintains film flexibility
• supports manufacturing

Directional Release Should Be Measured From Both Sides

A useful experimental setup can separately quantify material moving:

• through the mucosa-facing side
• through the backing side

This directly tests whether the architecture is directional.

One-Sided Dissolution Testing Can Miss Backing Performance

If a bilayer film is simply placed in a large dissolution vessel, researchers may not know which surface contributed most to release.

Directional testing requires controlled geometry.

Side-by-Side Cells Can Separate Release Directions

Specialized diffusion-cell systems can position the film between two compartments.

This allows researchers to quantify:

• release toward one surface
• release toward the other

Directional Release and Directional Permeation Are Not the Same

A backing layer may successfully reduce outward peptide release while the peptide still crosses mucosa poorly.

The formulation must therefore satisfy two separate questions:

• Is peptide directed toward tissue?
• Does it subsequently cross tissue?

A Permeation Enhancer Can Be Placed in the Mucoadhesive Layer

This allows the enhancer to hydrate close to the epithelial surface rather than being distributed throughout a nonfunctional backing layer.

Layer placement can therefore influence local enhancer exposure.

Peptide and Enhancer Can Be Co-Located

Co-incorporating peptide and enhancer in the mucosal layer may help maintain a defined:

• peptide concentration
• enhancer concentration
• peptide-to-enhancer ratio

near the epithelial surface during hydration.

Film Hydration Can Change Directionality Over Time

As the mucosal layer absorbs water:

• its thickness can increase
• polymer mobility can increase
• peptide can begin diffusing

If the backing layer also hydrates substantially, its barrier properties may change.

Directional Performance Should Therefore Be Time-Resolved

A backing layer that restricts release during the first 30 minutes may behave differently after several hours.

Researchers should examine the relevant residence period.

Backing Layers Can Also Provide Mechanical Support

The less soluble layer may help:

• reduce folding
• improve handling
• maintain dimensional stability

while the hydrated mucosal layer becomes softer.

Mechanical Mismatch Between Layers Can Cause Curling

If one layer expands substantially more than the other after hydration, internal stress can cause:

• curvature
• edge lifting
• delamination

Swelling behaviour therefore matters to directional delivery.

Total Film Thickness Can Increase With Multilayer Design

Adding a backing layer can increase:

• overall thickness
• mass
• stiffness

This creates a tradeoff between directional control and physical bulk.

More Layers Do Not Automatically Mean Better Performance

A multilayer system also introduces greater:

• manufacturing complexity
• quality-control burden
• interface variability

The added layer needs to provide a measurable advantage.

Single-Layer and Bilayer Films Should Be Compared Directly

Using otherwise similar formulations allows researchers to determine what the backing layer actually changes.

Useful comparisons include:

• peptide permeation
• reverse release
• mechanical properties
• mucoadhesion

A Bilayer Can Reduce Measured Flux Compared With a Monolayer

Adding structural complexity can alter:

• hydration
• peptide release
• available contact area

Therefore, directional design may involve performance tradeoffs rather than improving every endpoint simultaneously.

Recent Peptide Research Demonstrates This Tradeoff

A GLP-1 analogue study reported measurable peptide permeation from both monolayer and bilayer pullulan-based films, with lower measured flux from the bilayer under the tested ex vivo conditions.

The backing architecture still provided a platform for directional formulation development.

Barrier Performance Must Be Considered Together With Permeation

A bilayer formulation can be valuable if it reduces peptide loss into saliva even when total ex vivo flux differs from a monolayer.

The relevant performance target depends on the intended design.

Multilayer Films Can Contain More Than Two Functional Zones

More complex systems could theoretically separate:

• peptide storage
• mucoadhesion
• permeation enhancer
• backing function

into different layers.

Each additional interface introduces further formulation complexity.

Research Note: A Bilayer Peptide Film Has Been Tested Directly Against Buccal Tissue

A 2026 primary study designed a bilayer system containing a pullulan-carboxymethyl cellulose mucoadhesive layer with a GLP-1 analogue and sodium glycodeoxycholate, combined with an Eudragit RLPO backing layer. The researchers evaluated physicochemical film properties and peptide permeation across ex vivo porcine buccal mucosa.

The work demonstrates directional peptide-film engineering rather than a universal bilayer recipe. Polymer choice, enhancer concentration, peptide loading, hydration, backing-layer behaviour, and mucosal permeability remained interconnected formulation variables.

Excipients Determine Much of the Architecture's Behaviour

The same peptide can be incorporated into films with different:

• polymers
• plasticizers
• enhancers
• backing materials

and show different release or permeability without any change to its amino-acid sequence.

This distinction is examined in Why Excipients Can Change Peptide Film Performance Without Changing the Peptide Itself.

What Multilayer-Film Research May Establish

A well-designed study may establish that under its conditions:

• two layers remain mechanically integrated
• a backing layer reduces reverse release
• peptide release becomes more directional
• mucoadhesion remains adequate
• peptide permeation occurs through buccal tissue
• a bilayer performs differently from a monolayer

What It Does Not Establish

These findings do not independently establish:

• human bioavailability
• clinical effectiveness
• universal superiority of bilayer films
• identical performance with another peptide
• identical behaviour at every oral site
• long-term human residence or tolerability
• performance of a finished commercial product

Directional Delivery Is a Geometry Problem as Well as a Chemistry Problem

Multilayer peptide films show how dosage-form architecture can control where formulation components are allowed to move.

The peptide-containing layer provides the mucosa-facing formulation environment. The backing layer restricts unwanted release, contributes structural support, and changes hydration geometry. The interface between those layers determines whether the system remains intact.

Accurate interpretation should therefore identify the number of layers, material assigned to each layer, casting sequence, interlayer compatibility, total thickness, hydration behaviour, direction-specific release, peptide permeation, and comparison with a monolayer before concluding that a multilayer film provides effective directional delivery.